- Home
- All Stock List
- NSE
- Sigachi Industries Ltd Share Price
Sigachi Industries Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap
40.99
-0.79 (-1.89%)
-
Underperforms Index
-38.36%
Return (1Y)
Underperformed Nifty 50 by 46.01%
-
More Volatile
2.8%
Standard Deviation (1Y)
Higher than Nifty 50 by 1.85%
-
Inconsistent Performer
3/12
Months
underperformed Nifty 50
-
AxisDirect View
No View
76
34
News & Announcements
-
Sigachi Industries inks MoU with Czech Republic-based Respilon Group
28 - Apr - 2025 12:00 | 4 days ago
Headquartered in the Czech Republic, Respilon is an innovation-driven nanofiber R&D company.
Sigachi and Respilon will collaborate to develop, manufacture, and commercialize drug delivery solutions based on Respilon?s proprietary NUENEX nanofiber technology.
The two entities would focus on the development of Invisible Patch and Powder-based pharmaceutical delivery formats.
The collaboration includes developing commercialization strategies for relevant APIs and formulations, leveraging nanofiber encapsulation technology.
Amit Raj Sinha, managing director and CEO of Sigachi Industries, said: Partnering with Respilon aligns perfectly with our vision to deliver next-generation pharmaceutical solutions that improve therapeutic outcomes and elevate the patient experience. We are excited about the possibilities NUENEX technology offers to revolutionize drug delivery systems globally.?
Telangana-based Sigachi Industries is engaged in the manufacturing of microcrystalline cellulose (MCC), which is widely used in the pharmaceutical, food, beverage, cosmetic, and paint industries. The most common uses of MCC are in vitamin supplements and tablets. It also acts as a bulking agent in food production. MCC is produced from refined wood pulp, which is imported by the company.
The company reported 32.52% jump in consolidated net profit to Rs 21.35 crore in Q3 FY25 from Rs 16.11 crore posted in Q3 FY24. Revenue from operations grew by 25.66% to Rs 139.41 crore in Q3 FY25 from Rs 110.94 crore registered in Q3 FY24.
The scrip rose 0.30% to currently trade at Rs 42.95 on the BSE.
Powered by Capital Market - Live News
-
Sigachi MENA FZCO, a wholly owned subsidiary of Sigachi Industries, has signed a Memorandum of Understanding (MoU) with Respilon, an innovation-driven nanofiber R&D company headquartered in the Czech Republic. This partnership marks a significant milestone in Sigachi's strategy to expand into advanced drug delivery technologies.
Sigachi and Respilon will collaborate to develop, manufacture, and commercialize drug delivery solutions based on Respilon's proprietary NUENEX? nanofiber technology. The collaboration includes developing commercialization strategies for relevant APIs and formulations, leveraging nanofiber encapsulation technology.
Powered by Capital Market - Live News
-
Sigachi Industries announces board meeting date
85 days ago
-
Sigachi MENA FZCO, a wholly owned subsidiary of Sigachi Industries, has signed a Memorandum of Understanding (MoU) with Respilon, an innovation-driven nanofiber R&D company headquartered in the Czech Republic. This partnership marks a significant milestone in Sigachi's strategy to expand into advanced drug delivery technologies.
Sigachi and Respilon will collaborate to develop, manufacture, and commercialize drug delivery solutions based on Respilon's proprietary NUENEX? nanofiber technology. The collaboration includes developing commercialization strategies for relevant APIs and formulations, leveraging nanofiber encapsulation technology.
Powered by Capital Market - Live News
-
Sigachi Industries announces board meeting date
85 days ago
-
Sigachi Industries establishes state-of-the-art R&D Center in Hyderabad
04 - Feb - 2025 12:00 | 87 days ago
Sigachi Industries is establishing a state-of-the-art R&D Center in Hyderabad to enhance its Research and Development (R&D) capabilities. This strategic initiative involves an investment of up to USD 1 million with the objective of bringing its critical API developments and Analytical Efforts under one roof.
Powered by Capital Market - Live News
-
Sigachi Industries inks MoU with Czech Republic-based Respilon Group
28 - Apr - 2025 12:00 | 4 days ago
Headquartered in the Czech Republic, Respilon is an innovation-driven nanofiber R&D company.
Sigachi and Respilon will collaborate to develop, manufacture, and commercialize drug delivery solutions based on Respilon?s proprietary NUENEX nanofiber technology.
The two entities would focus on the development of Invisible Patch and Powder-based pharmaceutical delivery formats.
The collaboration includes developing commercialization strategies for relevant APIs and formulations, leveraging nanofiber encapsulation technology.
Amit Raj Sinha, managing director and CEO of Sigachi Industries, said: Partnering with Respilon aligns perfectly with our vision to deliver next-generation pharmaceutical solutions that improve therapeutic outcomes and elevate the patient experience. We are excited about the possibilities NUENEX technology offers to revolutionize drug delivery systems globally.?
Telangana-based Sigachi Industries is engaged in the manufacturing of microcrystalline cellulose (MCC), which is widely used in the pharmaceutical, food, beverage, cosmetic, and paint industries. The most common uses of MCC are in vitamin supplements and tablets. It also acts as a bulking agent in food production. MCC is produced from refined wood pulp, which is imported by the company.
The company reported 32.52% jump in consolidated net profit to Rs 21.35 crore in Q3 FY25 from Rs 16.11 crore posted in Q3 FY24. Revenue from operations grew by 25.66% to Rs 139.41 crore in Q3 FY25 from Rs 110.94 crore registered in Q3 FY24.
The scrip rose 0.30% to currently trade at Rs 42.95 on the BSE.
Powered by Capital Market - Live News
-
Sigachi MENA FZCO, a wholly owned subsidiary of Sigachi Industries, has signed a Memorandum of Understanding (MoU) with Respilon, an innovation-driven nanofiber R&D company headquartered in the Czech Republic. This partnership marks a significant milestone in Sigachi's strategy to expand into advanced drug delivery technologies.
Sigachi and Respilon will collaborate to develop, manufacture, and commercialize drug delivery solutions based on Respilon's proprietary NUENEX? nanofiber technology. The collaboration includes developing commercialization strategies for relevant APIs and formulations, leveraging nanofiber encapsulation technology.
Powered by Capital Market - Live News
-
Sigachi Industries announces board meeting date
85 days ago
-
Sigachi Industries establishes state-of-the-art R&D Center in Hyderabad
04 - Feb - 2025 12:00 | 87 days ago
Sigachi Industries is establishing a state-of-the-art R&D Center in Hyderabad to enhance its Research and Development (R&D) capabilities. This strategic initiative involves an investment of up to USD 1 million with the objective of bringing its critical API developments and Analytical Efforts under one roof.
Powered by Capital Market - Live News
-
Sigachi Industries inks MoU with Czech Republic-based Respilon Group
28 - Apr - 2025 12:00 | 4 days ago
Headquartered in the Czech Republic, Respilon is an innovation-driven nanofiber R&D company.
Sigachi and Respilon will collaborate to develop, manufacture, and commercialize drug delivery solutions based on Respilon?s proprietary NUENEX nanofiber technology.
The two entities would focus on the development of Invisible Patch and Powder-based pharmaceutical delivery formats.
The collaboration includes developing commercialization strategies for relevant APIs and formulations, leveraging nanofiber encapsulation technology.
Amit Raj Sinha, managing director and CEO of Sigachi Industries, said: Partnering with Respilon aligns perfectly with our vision to deliver next-generation pharmaceutical solutions that improve therapeutic outcomes and elevate the patient experience. We are excited about the possibilities NUENEX technology offers to revolutionize drug delivery systems globally.?
Telangana-based Sigachi Industries is engaged in the manufacturing of microcrystalline cellulose (MCC), which is widely used in the pharmaceutical, food, beverage, cosmetic, and paint industries. The most common uses of MCC are in vitamin supplements and tablets. It also acts as a bulking agent in food production. MCC is produced from refined wood pulp, which is imported by the company.
The company reported 32.52% jump in consolidated net profit to Rs 21.35 crore in Q3 FY25 from Rs 16.11 crore posted in Q3 FY24. Revenue from operations grew by 25.66% to Rs 139.41 crore in Q3 FY25 from Rs 110.94 crore registered in Q3 FY24.
The scrip rose 0.30% to currently trade at Rs 42.95 on the BSE.
Powered by Capital Market - Live News
-
Sigachi MENA FZCO, a wholly owned subsidiary of Sigachi Industries, has signed a Memorandum of Understanding (MoU) with Respilon, an innovation-driven nanofiber R&D company headquartered in the Czech Republic. This partnership marks a significant milestone in Sigachi's strategy to expand into advanced drug delivery technologies.
Sigachi and Respilon will collaborate to develop, manufacture, and commercialize drug delivery solutions based on Respilon's proprietary NUENEX? nanofiber technology. The collaboration includes developing commercialization strategies for relevant APIs and formulations, leveraging nanofiber encapsulation technology.
Powered by Capital Market - Live News
-
Sigachi Industries announces board meeting date
85 days ago
-
Sigachi MENA FZCO, a wholly owned subsidiary of Sigachi Industries, has signed a Memorandum of Understanding (MoU) with Respilon, an innovation-driven nanofiber R&D company headquartered in the Czech Republic. This partnership marks a significant milestone in Sigachi's strategy to expand into advanced drug delivery technologies.
Sigachi and Respilon will collaborate to develop, manufacture, and commercialize drug delivery solutions based on Respilon's proprietary NUENEX? nanofiber technology. The collaboration includes developing commercialization strategies for relevant APIs and formulations, leveraging nanofiber encapsulation technology.
Powered by Capital Market - Live News
-
Sigachi Industries announces board meeting date
85 days ago
-
Sigachi Industries establishes state-of-the-art R&D Center in Hyderabad
04 - Feb - 2025 12:00 | 87 days ago
Sigachi Industries is establishing a state-of-the-art R&D Center in Hyderabad to enhance its Research and Development (R&D) capabilities. This strategic initiative involves an investment of up to USD 1 million with the objective of bringing its critical API developments and Analytical Efforts under one roof.
Powered by Capital Market - Live News
Stock Trivia
FII shareholding in Sigachi Industries Ltd has decreased by -60.34% since past 3 Months
MF shareholding in Sigachi Industries Ltd has increased by 466.67% since past 1 Year
FII shareholding in Sigachi Industries Ltd has decreased by -60.34% since past 3 Months
FII shareholding in Sigachi Industries Ltd has decreased by -95.99% since past 1 Year
MF shareholding in Sigachi Industries Ltd has increased by 466.67% since past 1 Year
FII shareholding in Sigachi Industries Ltd has decreased by -60.34% since past 3 Months
MF shareholding in Sigachi Industries Ltd has increased by 466.67% since past 1 Year
